Related Experiment Videos
Head and neck liposarcomas: a 32 years experience
Saïd Gritli1, Khaled Khamassi, Ali Lachkhem
1Department of Otorhinolaryngology-Head and Neck Surgery, Salah Azaïz Institute, Boulevard 9 Avril, Bab Saadoun, Tunis, Tunisia.
Auris, Nasus, Larynx
|October 28, 2009
Summary
Head and neck liposarcomas are rare tumors. Surgical excision is the primary treatment, with prognosis depending on tumor grade and stage. Survival rates vary significantly based on treatment modality.
Area of Science:
- Oncology
- Surgical Pathology
Background:
- Liposarcomas are malignant soft tissue tumors originating from adipose tissue.
- Head and neck liposarcomas are rare, presenting unique diagnostic and therapeutic challenges.
Purpose of the Study:
- To investigate the natural history, clinical presentation, treatment outcomes, and prognosis of liposarcomas in the head and neck region.
Main Methods:
- A retrospective analysis of 15 patients diagnosed and treated for head and neck liposarcomas between 1969 and 2001.
- Evaluation of surgical excision, radiotherapy, and chemotherapy as therapeutic modalities.
Main Results:
- The most common localizations were the neck and scalp. Complete surgical excision was achieved in 7 cases, with a 5-year survival rate of 87% for surgery alone.
- Incomplete excision followed by radiotherapy yielded a 75% 5-year survival rate. Radiotherapy alone resulted in 0% survival.
- Recurrence occurred in 53.3% of cases, with prognosis significantly influenced by histological grade and clinical stage.
Conclusions:
- Surgical excision remains the cornerstone for treating head and neck liposarcomas.
- Histological grade and clinical stage are critical determinants of patient prognosis.
- Multimodality treatment may be necessary for optimal outcomes in select cases.